Examining Sirtuin-1 Levels and Inflammation Markers in Behcet's Disease: A Pilot Study

Area of Science:

• Immunology
• Rheumatology
• Biochemistry

Background:

• Behcet's disease (BD) is characterized by inflammation driven by cytokines like IL-6 and TNF-α.
• Sirtuin-1 (SIRT1) is a protein deacetylase with potential roles in inflammation.
• Investigating SIRT1's role in BD could identify new disease activity markers.

Purpose of the Study:

• To measure circulatory SIRT1 levels in Behcet's disease patients.
• To correlate SIRT1 levels with disease activity and inflammatory markers.
• To explore SIRT1's potential as a biomarker for BD activity and vascular involvement.

Main Methods:

• Compared SIRT1 levels in 40 BD patients and 40 healthy controls.
• Assessed disease activity using the Behcet Disease Current Activity Form (BDCAF).
• Measured inflammatory markers including C-reactive protein, IL-6, and TNF-α.

Main Results:

• BD patients showed higher C-reactive protein, IL-6, and TNF-α than controls.
• Circulatory SIRT1 levels did not differ between BD patients and controls.
• SIRT1 levels were similar across disease activity groups and in patients with/without anti-TNF-α treatment.
• Lower SIRT1 levels were observed in BD patients with concurrent vascular and ocular involvement.

Conclusions:

• Circulating SIRT1 levels are not significantly altered in Behcet's disease patients overall.
• SIRT1 levels do not appear to be reliable markers for general disease activity or response to anti-TNF-α therapy in BD.
• Reduced SIRT1 concentrations may be linked to vascular injury in BD patients with vascular and ocular involvement.